SEARCH

SEARCH BY CITATION

References

  • Abildgaard U, Sandset PM, Hammerstrom J, Gjestvang FT, Tveit A. 2009. Management of pregnant women with mechanical heart valve prosthesis: thromboprophylaxis with low molecular weight heparin. Thromb Res 124:262267.
  • Agunanne E. 2008. Peripartum cardiomyopathy presenting with a pulmonary embolism: an unusual case. South Med J 101:646647.
  • Ahearn GS, Hadjiliadis D, Govert JA, Tapson VF. 2002. Massive pulmonary embolism during pregnancy successfully treated with recombinant tissue plasminogen activator: a case report and review of treatment options. Arch Intern Med 162:12211227.
  • Al-Lawati AA, Venkitraman M, Al-Delaime T, Valliathu J. 2002. Pregnancy and mechanical heart valves replacement: dilemma of anticoagulation. Eur J Cardiothorac Surg 22:223227.
  • Amos A, Jaber WA, Russell SD. 2006. Improved outcomes in peripartum cardiomyopathy with contemporary. Am Heart J 152:509513.
  • Arnaout MS, Kazma H, Khalil A, Shasha N, Nasrallah A, Karam K, Alam SE. 1998. Is there a safe anticoagulation protocol for pregnant women with prosthetic valves. Clin Exp Obstet Gynecol 25:101104.
  • Aventis Pharmaceuticals. 2004. Lovenox Injection [packet insert]. Bridgewater, NJ: Aventis Pharmaceuticals.
  • Barbour LA, Pickard J. 1995. Controversies in thromhoenibolic disease during pregnancy: a critical review. Obstet Gynecol 86:621633.
  • Barbour LA, Oja JL, Schultz LK. 2004. A prospective trial that demonstrates that dalteparin requirements increase in pregnancy to maintain therapeutic levels of anticoagulation. Am J Obstet Gynecol 191:10241029.
  • Barco S, Nijkeuter M, Middeldorp S. 2013. Pregnancy and venous thromboembolism. Semin Thromb Hemost 39:549558.
  • Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM, Vandvik PO. 2012. VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):e691Se736S.
  • Bayer Schering Pharma AG. Summary of product. Characteristics: rivaroxaban. Date of text revision: May 2009. Accessed date: 2013- 10-12.
  • Berndt N, Khan I, Gallo R. 2000. A complication in anticoagulation using low-molecular weight heparin in a patient with mechanical valve prosthesis: a case report. J Heart Valve Dis 9:844846.
  • Blanco-Molina A, Rota LL, Di Micco P, Brenner B, Trujillo-Santos J, Ruiz-Gamietea A, Monreal M. 2010. Venous thromboembolism during pregnancy, postpartum or during contraceptive use. Thromb Haemost 103:306311.
  • Blickstein D, Blickstein I. 2002. The risk of fetal loss associated with warfarin anticoagulation. Int J Gynaecol Obstet 78:221225.
  • Boehringer Ingelheim Canada Ltd. 2012. Product monograph-Dabigatran etexilate capsules.
  • Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, et al. 2008. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the society of cardiovascular anesthesiologists, society for cardiovascular angiography and interventions, and society of thoracic surgeons. J Am Coll Cardiol 52(13):e1e142.
  • Born D, Martinez EE, Almeida PA, Santos DV, Carvalho AC, Moron AF, Miyasaki CH, Moraes SD, Ambrose JA. 1992. Pregnancy in patients with prosthetic heart valves: the effects of anticoagulation on mother, fetus and neonate. Am Heart J 124:413417.
  • Bourjeily G, Paidas M, Khalil H, Rosene-Montella K, Rodger M. 2010. Pulmonary embolism in pregnancy. Lancet 375:500512.
  • Box LC, Hanak V, Arciniegas JG. 2004. Dual coronary emboli in peripartum cardiomyopathy. Tex Heart Inst J 31:442444.
  • Brancazio LR, Roperti KA, Stierer R, Laifer SA. 1995. Pharmacokinetics and pharmacodynamics of subcutaneous heparin during the early third trimester of pregnancy. Am J Obstet Gynecol 173:12401245.
  • Bremme KA. 2003. Haemostatic changes in pregnancy. Best Pract Res Clin Haematol 16:153168.
  • Brenner B. 2004. Haemostatic changes in pregnancy. Thromb Res 114:409414.
  • Briggs GG, Freeman RK, Yatte SJ. 2008. Drugs in pregnancy and lactation, 8th ed. Philadelphia, PA, Wolters Kluwer.
  • Bryg RJ, Gordon PR, Kudesia VS, Bhatia RK. 1989. Effect of pregnancy on pressure gradient in mitral stenosis. Am J Cardiol 63:384386.
  • Casele H, Grobman WA. 2006. Cost-effectiveness of thromboprophylaxis with intermittent pneumatic compression at cesarean delivery. Obstet Gynecol 108:535540.
  • Casele H, Haney EI, James A, Rosene-Montella K, Carson M. 2006. Bone density changes in women who receive thromboprophylaxis in pregnancy. Am J Obstet Gynecol 195:11091113.
  • Casele HL, Laifer SA, Woelkers DA, Venkataramanan R. 1999. Changes in the pharmacokinetics of the low-molecular-weight heparin enoxaparin sodium during pregnancy. Am J Obstet Gynecol 181:11131117.
  • Chan F, Ngan Kee WD. 1999. Idiopathic dilated cardiomyopathy presenting in pregnancy. Can J Anaesth 46:11461149.
  • Chan WS, Anand S, Ginsberg JS. 2000. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med 160:191196.
  • Chen WW, Chan CS, Lee PK, Wang RY, Wong VC. 1982. Pregnancy in patients with prosthetic heart valves: an experience with 45 pregnancies. Q J Med 51:358365.
  • Clark P, Walker I. 2001. The phenomenon known as acquired activated protein C resistance. Br J Haematol 114:767773.
  • Consensus Reports. 2002. Anticoagulation and enoxaparin use in patients with prosthetic heart valves and/or pregnancy. Clinical cardiology consensus reports, vol. 3. American Health Consultants Atlanta (GA) 2002;3:120.
  • Conti E, Zezza L, Ralli E, Comito C, Sada L, Passerini J, Caserta D, Rubattu S, Autore C, Moscarini M, et al. 2013. Pulmonary embolism in pregnancy. J Thromb Thrombolysis. Epub ahead of print.
  • Cotrufo M, De Feo M, De Santo LS, Romano G, Della Corte A, Renzulli A, Gallo C. 2002. Risk of warfarin during pregnancy with mechanical valve prostheses. Obstet Gynecol 99:3540.
  • Dahlman TC. 1999. Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin. Am J Obstet Gynecol 168:12651270.
  • DiCarlo-Meacham A, Dahlke J. 2011. Atrial fibrillation in pregnancy. Obstet Gynecol 117:489492.
  • Elkayam U, Bitar F. 2005. Valvular heart disease and pregnancy: prosthetic valves part II. J Am Coll Cardiol 46:403410.
  • Elkayam U, Goland S. 2012. The search for a safe and effective anticoagulation regimen in pregnant women with mechanical prosthetic heart valves. J Am Coll Cardiol 59:11161118.
  • Elkayam U, Singh H, Irani A, Akhter MW. 2004. Anticoagulation in pregnant women with prosthetic heart valve. J Cardiovasc Pharmacol Ther 9:107115.
  • Elkayam U. 2011. Clinical characteristics of peripartum cardiomyopathy in the United States: diagnosis, prognosis, and management. J Am Coll Cardiol 9;58(7):659670.
  • Evans W, Laifer SA, McNanley TJ, Ruzycky A. 1997. Management of thromboembolic disease associated with pregnancy. J Matern Fetal Med 6:2127.
  • Fan J, Goland S, Khatri N, Elkayam U. 2011. Monitoring of anti Xa in pregnant patients with mechanical prosthetic valves receiving low molecular weight heparin: peak or trough levels? (abstr). Circulation 122:A18219.
  • Fasullo S, Scalzo S, Maringhini G, Ganci F, Cannizzaro S, Basile I, Cangemi D, Terrazzino G, Parrinello G, Sarullo FM, et al. 2011. Six-month echocardiographic study in patients with submassive pulmonary embolism and right ventricle dysfunction: comparison of thrombolysis with heparin. Am J Med Sci 341:3339.
  • Finkelstein Y, Chitayat D, Schechter T, Keating S, Toi A, Koren G. 2005. Motherisk rounds: warfarin embryopathy following low-dose maternal exposure. J Obstet Gynaecol Can 27:702706.
  • Flessa HC, Kapstrom AB, Glueck HI, Will JJ. 1965. Placental transport of heparin. Am J Obstet Gynecol 93:570573.
  • Forfar JC, Miller HC, Toft AD. 1979. Occult thyrotoxicosis: a correctable cause of “idiopathic” atrial fibrillation. Am J Cardiol 44:912.
  • Franchini M. 2006. Haemostasis and pregnancy. Thromb Haemost 95:401413.
  • Friedrich E, Hameed AB. 2010. Fluctuations in anti-factor Xa levels with therapeutic enoxaparin anticoagulation in pregnancy. J Perinatol 30:253257.
  • Geelani MA, Singh S, Verma A, Nagesh A, Betigeri V, Nigam M. 2005. Anticoagulation in patients with mechanical valves during pregnancy. Asian Cardiovasc Thorac Ann 13:3033.
  • Ginsberg JS, Kowalchuk G, Hirsh J, Brill-Edwards P, Burrows R. 1989. Heparin therapy during pregnancy. Risks to the fetus and the mother. Arch Intern Med 149:22332236.
  • Goland S, Elkayam U. 2012. Anticoagulation in pregnancy. Cardiol Clin 30:395405.
  • Goland S, Modi K, Bitar F, Janmohamed M, Mirocha JM, Czer LS, Illum S, Hatamizadeh P, Elkayam U. 2009. Clinical profile and predictors of complications in peripartum cardiomyopathy. J Card Fail 15:645665.
  • Gordon M, Gabbe S, Niebyl J, Simpson J. 2002. Maternal physiology in pregnancy. In: Gabbe SG , Niebyl JR , Simpson JL , editors. Normal and Problem Pregnancies, 4th ed. New York, Churchill Livingstone, p 6392.
  • Gowda RM, Punukollu G, Khan IA, Wilbur SL, Navarro VS, Vasavada BC, Sacchi TJ. 2003. Lone atrial fibrillation during pregnancy. Int J Cardiol 88:123124.
  • Greer IA. 2012. Thrombosis in pregnancy: updates in diagnosis and management. Hematology Am Soc Hematol Educ Program 2012:203207. doi: 10.1182/asheducation 2012.
  • Greer IA, Nelson-Piercy C. 2005. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood 106:401407.
  • Grewal J, Siu SC, Ross H, Mason J, Balint OH, Sermer M, Colman JM, Silversides CK. 2009. Pregnancy outcomes in women with dilated cardiomyopathy. J Am Coll Cardiol 55:4552.
  • Hameed A, Karaalp IS, Tummala PP, Wani OR, Canetti M, Akhter MW, Goodwin I, Zapadinsky N, Elkayam U. 2001. The effect of valvular heart disease on maternal and fetal outcome of pregnancy. J Am Coll Cardiol 37:893899.
  • Hameed A, Akhter MW, Bitar F, Khan SA, Sarma R, Goodwin TM, Elkayam U. 2005. Left atrial thrombosis in pregnant women with mitral stenosis and sinus rhythm. Am J Obstet Gynecol 193:501504.
  • Heit JA, Kobbervig CE, James AH, Petterson TM, Bailey KR, Melton LJ 3rd. 2005. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med 143:697706.
  • Holden EL, Ranu H, Sheth A, Shannon MS, Madden BP. 2011. Thrombolysis for massive pulmonary embolism in pregnancy. Reports of three cases and follow up over a two year period. Thromb Res 127:5859.
  • Horlocker TT, Wedel DJ, Benzon H, Brown DL, Enneking FK, Heit JA, Mulroy MF, Rosenquist RW, Rowlingson J, Tryba M, et al. 2003. Regional anesthesia in the anticoagulated patient: defining the risks. Reg Anesth Pain Med 28:172197.
  • Huang WH, Kirz DS, Gallee RC, Gordey K. 2000. First trimester use of recombinant tissue plasminogen activator in pulmonary embolism. Obstet Gynecol 96:838.
  • Ibebuogu UN, Thornton JW, Reed GL. 2007. An unusual case of peripartum cardiomyopathy manifesting with multiple thrombo-embolic phenomena. Thromb J 5:18.
  • Iturbe-Alessio I, Fonseca MC, Mutchinik O, Santos MA, Zajarías A, Salazar E. 1986. Risks of anticoagulant therapy in pregnant women with artificial heart valves. N Engl J Med 315:13901393.
  • Jacobson AF, Qvigstad E, Sandset P. 2003. Low molecular weight heparin (dalteparin) for the treatment of venous thromboembolism in pregnancy. BJOG 110:139144.
  • James A. 2011. Practice bulletin no. 123: thromboembolism in pregnancy. Obstet Gynecol 118:718729.
  • James AH. 2007. Prevention and management of venous thromboembolism in pregnancy. Am J Med 120(10 Suppl. 2):S26S34.
  • James AH. 2009. Venous thromboembolism in pregnancy. Arterioscler Thromb Vasc Biol 29:326331.
  • James AH. 2012. Prevention and treatment of venous thromboembolism in pregnancy. Clin Obstet Gynecol 55:774787.
  • James AH, Brancazio LR, Ortel TL. 2005a. Thrombosis, thrombophilia and thromboprophylaxis in pregnancy. Clin Adv Hematol Oncol 3:187197.
  • James AH, Bushnell CD, Jamison MG, Myers ER. 2005b. Incidence and risk factors for stroke in pregnancy and the puerperium. Obstet Gynecol 106:509516.
  • James AH, Jamison MG, Biswas MS, Brancazio LR, Swamy GK, Myers ER. 2006a. Acute myocardial infarction in pregnancy: a United States population-based study. Circulation 113:15641571.
  • James AH, Jamison MG, Brancazio LR, Myers ER. 2006b. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol 194:13111315.
  • Jha P, Jha S, Millane TA. 2005. Peripartum cardiomyopathy complicated by pulmonary embolism and pulmonary hypertension. Eur J Obstet Gynecol Reprod Biol 123:121123.
  • Khan AO. 2007. Optic nerve dysfunction in a child following low-dose maternal warfarin exposure. Ophthalmic Genet 28(3):183184.
  • Kjellberg U, Anderson NE, Rosen S, Tengborn L, Hellgren M. 1999. APC resistance and other haemostatic variables during pregnancy and puerperium. Thromb Haemost 81:527531.
  • Leonhardt G, Gaul C, Nietsch HH, Buerke M, Schleussner E. 2006. Thrombolytic therapy in pregnancy. J Thromb Thrombolysis 21:271276.
  • Lepercq J, Conard J, Borel-Derlon A, Darmon JY, Boudignat O, Francoual C, Priollet P, Cohen C, Yvelin N, Schved JF, et al. 2001. Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies. BJOG 108:11341140.
  • Lev-Ran O, Kramer A, Gurevitch J, Shapira I, Mohr R. 2000. Low molecular-weight heparin for prosthetic heart valves: treatment failure. Ann Thorac Surg 69:264265.
  • Lockshin MD. 2013. Anticoagulation in management of antiphospholipid antibody syndrome in pregnancy. Clin Lab Med 33:367376.
  • Mazzolai L, Hohlfeld P, Spertini F, Hayoz D, Schapira M, Duchosal MA. 2006. Fondaparinux is a safe alternative in case of heparin intolerance during pregnancy. Blood 108:15691570.
  • McGehee W. 1998. Anticoagulation in pregnancy. In: Elkayam U , Gleicher N , editors. Cardiac Problems in Pregnancy, 3rd ed. New York, Wiley-Liss, p 407417.
  • McLintock C. 2011. Anticoagulant therapy in pregnant women with mechanical prosthetic heat valves: no easy option. Thromb Res 127:5660.
  • McLintock C, McCowan LM, North RA. 2009. Maternal complications and pregnancy outcome in women with mechanical prosthetic heart valves treated with enoxaparin. BJOG 116:15851592.
  • Meschengieser SS, Fondevila CG, Santarelli MT, Lazzari MA. 1999. Anticoagulation in pregnant women with mechanical heart valve prostheses. Heart 82:2326.
  • Miller MA, Chalhoub M, Bourjeily G. 2011. Peripartum pulmonary embolism. Clin Chest Med 32:147164.
  • Monreal M, Lafoz E, Olive A, Del Rio L, Vedia C. 1994. Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindication to coumarin. Thromb Haemost 71:711.
  • Napporn AG, Kane A, Damorou JM, Dia AA, Diop IB, Sarr M, Ba SA, Diouf SM. 2000. Intraventricular thrombosis complicating peripartum idiopathic myocardiopathy. Ann Cardiol Angeiol (Paris) 49:309314.
  • Oran B, Lee-Parritz A, Ansell J. 2004. Low molecular weight heparin for the prophylaxis of thromboembolism in women with prosthetic mechanical heart valves during pregnancy. Thromb Haemost 92:747751.
  • Quinn B, Doyle B, Mclnerney J. 2004. Postnatal pre-cordial pain, pulmonary embolism or peripartum cardiomyopathy. Emerg Med J 21:746747.
  • Quinn J, Von Klemperer K, Brooks R, Peebles D, Walker F, Cohen H. 2009. Use of high intensity adjusted dose low molecular weight heparin in women with mechanical heart valves during pregnancy: a single-center experience. Haematologica 94:16081612.
  • Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, Cifkova R, Ferreira R, Foidart JM, Gibbs JS, Gohlke-Baerwolf C, Gorenek B, Iung B, et al. 2011. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the task force on the management of cardiovascular diseases during pregnancy of the European society of cardiology (ESC). Eur Heart J 32:31473197.
  • Reimold SC, Rutherford JD. 2003. Valvular heart disease in pregnancy: clinical practice. N Engl J Med 349:5259.
  • Robertson L, Wu O, Langhorne P, Twaddle S, Clark P, Lowe GD, Walker ID, Greaves M, Brenkel I, Regan L, et al. 2006. Thrombophilia in pregnancy: a systematic review. Br J Haematol 132:171196.
  • Rodie VA, Thomson AJ, Stewart FM, Quinn AJ, Walker ID, Greer IA. 2002. Low molecular weight heparin for the treatment of venous thromboembolism in pregnancy: a case series. BJOG 109:10201024.
  • Rosenkranz A, Hiden M, Leschnik B, Weiss EC, Schlembach D, Lang U, Gallistl S, Muntean W. 2008. Calibrated automated thrombin generation in normal uncomplicated pregnancy. Thromb Haemost 99:331337.
  • Rowan JA, McCowan LM, Raudkivi PJ, North RA. 2001. Enoxaparin treatment in women with mechanical heart valves during pregnancy. Am J Obstet Gynecol 185:633637.
  • Sadler L, MeCowan L, White H, Stewart A, Bracken M, North R. 2000. Pregnancy outcomes and cardiac complications in women with mechanical, bioprosthetic and homogralt valves. BJOG 107:245253.
  • Sanson BJ, Lensing AW, Prins MH, Ginsberg JS, Barkagan ZS, Lavenne-Pardonge E, Brenner B, Dulitzky M, Nielsen JD, Boda Z, et al. 1999. Safety of low-molecular-weight heparin in pregnancy: a systematic review. Thromb Haemost 81:668672.
  • Sbarouni E, Oakley CM. 1994. Outcome of pregnancy in women with valve prostheses. Br Heart J 71:196201.
  • Schneider D, Heilmann L, Harenberg J. 1995. Placental transfer of low-molecular weight heparin. Geburtshilfe Frauenheilkd 55:9398.
  • Schwartzenberg S, Perlman S, Levy R, Elkayam U, Goland S. 2013. Mechanical heart valve thrombosis in pregnancy. J Heart Valve Dis in press.
  • Shimamoto T, Marui A, Oda M, Tomita S, Nakajima H, Takeuchi T, Komeda M. 2008. A case of peripartum cardiomyopathy with recurrent left ventricular apical thrombus. Circ J 72:853854.
  • Shotan A, Ostrzega E, Mehra A, Johnson JV, Elkayam U. 1997. Incidence of arrhythmias in normal pregnancy and relation to palpitations, dizziness, and syncope. Am J Cardiol 79:10611064.
  • Sillesen M, Hjortdal V, Vejlstrup N, Sørensen K. 2011. Pregnancy with prosthetic heart valves: 30 years' nationwide experience in Denmark. Eur J Cardiothorac Surg 40:448454.
  • Siu SC, Sermer M, Harrison DA, Grigoriadis E, Liu G, Sorensen S, Smallhorn JF, Farine D, Amankwah KS, Spears JC, et al. 1997. Risk and predictors for pregnancy-related complications in women with heart disease. Circulation 96:27892794.
  • Siu SC, Sermer M, Colman JM, Alvarez AN, Mercier LA, Morton BC, Kells CM, Bergin ML, Kiess MC, Marcotte F, et al. 2001. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 104:515552.
  • Sliwa K, Hilfiker-Kleiner D, Petrie MC, Mebazaa A, Pieske B, Buchmann E, Regitz-Zagrosek V, Schaufelberger M, Tavazzi L, van Veldhuisen DJ, et al. 2010. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the heart failure association of European Society of Cardiology Working Group on Peripartum Cardiomypathy. Eur J Heart Fail 12:767778.
  • Srivastava AK, Gupta AK, Singh AV, Husain T. 2002. Effect of oral anticoagulant during pregnancy with prosthetic heart valve. Asian Cardiovasc Thorac Ann 10:306309.
  • Stergiopoulos K, Shiang E, Bench T. 2011. Pregnancy in patients with pre-existing cardiomyopathies. J Am Coll Cardiol 58:337350.
  • te Raa GD, Ribbert LS, Snijder RJ, Biesma DH. 2009. Treatment options in massive pulmonary embolism during pregnancy; a case report and review of the literature. Thromb Res 124:15.
  • Trukhacheva E, Scharff M, Gardner M, Lakkis N. 2005. Massive pulmonary embolism in pregnancy treated with tissue plasminogen activator. Obstet Gynecol 106:11561158.
  • Vijayan V, Rachel T. 2012. Pregnancy outcomes compared in women with mechanical heart valve replacements anticoagulated with warfarin and enoxaparin in pregnancy. Med J Malaysia 67:591594.
  • Vitale N, De Eeo M, De Santo LS, Pollice A, Tedesco N, Cotrufo M. 1999. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol 33:16371641.
  • Weitz JI. 1997. Low-molecular-weight heparins. N Engl J Med 337:688698.
  • Wesseling J, Van Driel D, Heymans HS, Rosendaal FR, Geven-Boere LM, Smrkovsky M, Touwen BC, Sauer PJ, Van der Veer E. 2001. Coumarins during pregnancy: long-term effects on growth and development of school-age children. Thromb Haemost 85:609613.
  • Whittemore R, Hobbins JC, Engle MA. 1982. Pregnancy and its outcome in women with and without surgical treatment of congenital heart disease. Am J Cardiol 50:641651.
  • Yarnoz MJ, Curtis AB. 2008. More reasons why men and women are not the same (gender differences in electrophysiology and arrythmias). Am J Cardiol 101:12911296.
  • Yinon Y, Siu SC, Warshafsky C, Maxwell C, McLeod A, Colman JM, Sermer M, Silversides CK. 2009. Use of low molecular weight heparin in pregnant women with mechanical heart valves. Am J Cardiol 104:12591263.